Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on September 3, 2025
WillScot Announces Leadership Transition
GlobeNewswire
·
September 3, 2025
President and COO Tim Boswell to Succeed Brad Soultz as Chief Executive Officer Worthing Jackman, Chairman of the Board, Named Executive Chairman of the Board Jeff Sagansky Appointed Lead Independent Director PHOENIX, Sept. 03, 2025 (GLOBE NEWSWIRE) -- …
New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
GlobeNewswire
·
September 3, 2025
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies1 that …
Actelis Networks to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 3, 2025
FREMONT, Calif, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced that its …
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
GlobeNewswire
·
September 3, 2025
– Expands Avadel’s pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia – – Initial pharmacokinetic (PK) and comparative bioavailability study to initiate in fourth quarter 2025 …
Faraday Future Founder and Co-CEO YT Jia Makes Second Stock Purchase Under 10b5-1 Plan, Underscoring Confidence in the Company’s Long-Term Strategy
GlobeNewswire
·
September 3, 2025
The Company also urges all stockholders to vote FOR all proposals for the FF Special Meeting of Stockholders occurring on September 19. LOS ANGELES, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future …
374Water Announces Open-Market Purchases of Company Stock by Board Members and Senior Management
GlobeNewswire
·
September 3, 2025
DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced recent …
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire
·
September 3, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2
GlobeNewswire
·
September 3, 2025
WARREN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the highest risk of …
Drilling Commences at Sherlock Crossing Gold-Antimony Prospect
GlobeNewswire
·
September 3, 2025
HIGHLIGHTS A maiden reverse circulation (RC) drilling program is underway at Sherlock Crossing in the West Pilbara, testing high-grade Au-Sb mineralisation at the historic Clarke Mine. The drill program consists of 8 holes on 4 sections for ~1,000 m RC …
Rail Vision Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
GlobeNewswire
·
September 3, 2025
Ra’anana, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced that it has received a …
Kronos Worldwide, Inc. Prices Private Offering of an Additional €75 Million of 9.50% Senior Secured Notes Due 2029
GlobeNewswire
·
September 3, 2025
Dallas, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE: KRO) (the “Company”) announced today that its wholly-owned subsidiary, Kronos International, Inc. (“KII”), has agreed to sell €75 million aggregate principal amount of …
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
GlobeNewswire
·
September 3, 2025
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute, a global clinical insights …
Motorsport Games to Present at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
MIRAMAR, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or “the Company”), a racing game developer, publisher, and esports ecosystem provider of official motorsport racing series, announced today that …
Radiance Biopharma Signs Exclusive License For ‘First In Class’ c-Met/EGFR Targeted Nano Antibody ADC
GlobeNewswire
·
September 3, 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or "Company"), a clinical-stage biotechnology company, announced that it has signed an Exclusive License Agreement with Novatim Immune Therapeutics (Zhejiang) CO., LTD. , (“ …
Dynagas LNG Partners LP Announces Date for the Release of the Second Quarter and Six Month 2025 Results
GlobeNewswire
·
September 3, 2025
ATHENS, Greece, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (NYSE: “DLNG”) (“Dynagas Partners” or the “Partnership”), an owner and operator of LNG carriers, today announced that it will release its financial results for the second quarter …
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
GlobeNewswire
·
September 3, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
XPO Provides North American LTL Operating Data for August 2025
GlobeNewswire
·
September 3, 2025
GREENWICH, Conn., Sept. 03, 2025 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for August 2025. LTL tonnage per day decreased 4.7%, as …
Longeveron® Announces Key Leadership Updates
GlobeNewswire
·
September 3, 2025
Than Powell, Chief Business Officer and head of business development, appointed Interim CEO Dr. Joshua Hare, co-founder and chief science officer, appointed Executive Chairman of the Board of Directors Wa’el Hashad to step down as CEO and Board member …
Methode Electronics Reschedules First Quarter Fiscal 2026 Earnings Release and Conference Call
GlobeNewswire
·
September 3, 2025
CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting system and power distribution applications, announced today that it has postponed the …
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
GlobeNewswire
·
September 3, 2025
MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing a multi-specific human anti-thymocyte …